Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Hearing loss in patients with Morquio A syndrome: A scoping review

L. Diaz-Ordoñez, PA. Duque-Cordoba, K. Silva-Cuero, JD. Gutierrez-Medina, W. Saldarriaga, L. Murgašová, M. Magner, E. Candelo, H. Pachajoa

. 2025 ; 104 (2) : e41128. [pub] 20250110

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, scoping review

Perzistentní odkaz   https://www.medvik.cz/link/bmc25010284

BACKGROUND: Hearing impairment is a prevalent clinical feature in Morquio syndrome (mucopolysaccharidosis IVA or MPS IVA) patients, often presenting in diverse forms: conductive, sensorineural, or a combination known as mixed hearing loss. The mixed form entails a blend of both conductive and sensorineural elements, typically exhibiting a progressive trajectory. This scoping review aimed to comprehensively analyze available evidence pertaining to the pathophysiology, classification, epidemiology, and clinical management of hearing loss in individuals with MPS IVA. METHODS: Targeted literature was searched using MEDLINE, Literatura Latino-Americana e do Caribe em Ciências da Saúde, Web of Science, the Cochrane Library, Trip Medical Database, Embase, ScienceDirect, and Google Scholar, with a second search cycle to identify gray literature. A systematic search strategy using Medical Subject Headings keywords was implemented: "Hearing Disorders" OR "Hearing Loss" AND "Mucopolysaccharidosis IV" or "Hearing Disorders" OR "Hearing Loss" AND "Mucopolysaccharidosis IV." The identified bibliography was uploaded to COVIDENCE platform for information management. Articles were screened by 3 independent reviewers following the eligibility criteria. RESULTS: Twenty-seven articles met the inclusion criteria, spanning information from 568 patients across 16 different countries. None of the studies had complete epidemiological information. Only 2 studies provided sufficient data to address the pathophysiology, while 3 addressed management and treatment. Hearing loss was reported in 210 of 568 patients. A total of 19.2% of patients reported recurrent ear infections. None of the studies reported vertigo, tinnitus, or dizziness in the patients. Pure-tone audiometry was the primary test used to diagnose and monitor auditory impairment in patients with Morquio syndrome. CONCLUSIONS: Five hundred sixty-eight patients with MPS IVA were identified, of whom 210 (37%) developed hearing loss, the most common of which was moderate. Despite the lack of information on the diagnosis and management of hearing loss in Morquio syndrome, this study found that approximately one-third of participants exhibited some form of auditory impairment, with the majority of these cases being sensorineural in nature.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25010284
003      
CZ-PrNML
005      
20250429135109.0
007      
ta
008      
250415s2025 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1097/MD.0000000000041128 $2 doi
035    __
$a (PubMed)39792720
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Diaz-Ordoñez, Lorena $u Centro de Investigaciones en Anomalías Congénitas y Enfermedades Raras (CIACER), Universidad Iccesi, Cali, Colombia $u Departamento de Ciencias Básicas Médicas, Facultad de Salud, Universidad Icesi, Cali, Colombia $u School of Basic Sciences, Universidad del Valle, Cali, Colombia $1 https://orcid.org/0000000231406332
245    10
$a Hearing loss in patients with Morquio A syndrome: A scoping review / $c L. Diaz-Ordoñez, PA. Duque-Cordoba, K. Silva-Cuero, JD. Gutierrez-Medina, W. Saldarriaga, L. Murgašová, M. Magner, E. Candelo, H. Pachajoa
520    9_
$a BACKGROUND: Hearing impairment is a prevalent clinical feature in Morquio syndrome (mucopolysaccharidosis IVA or MPS IVA) patients, often presenting in diverse forms: conductive, sensorineural, or a combination known as mixed hearing loss. The mixed form entails a blend of both conductive and sensorineural elements, typically exhibiting a progressive trajectory. This scoping review aimed to comprehensively analyze available evidence pertaining to the pathophysiology, classification, epidemiology, and clinical management of hearing loss in individuals with MPS IVA. METHODS: Targeted literature was searched using MEDLINE, Literatura Latino-Americana e do Caribe em Ciências da Saúde, Web of Science, the Cochrane Library, Trip Medical Database, Embase, ScienceDirect, and Google Scholar, with a second search cycle to identify gray literature. A systematic search strategy using Medical Subject Headings keywords was implemented: "Hearing Disorders" OR "Hearing Loss" AND "Mucopolysaccharidosis IV" or "Hearing Disorders" OR "Hearing Loss" AND "Mucopolysaccharidosis IV." The identified bibliography was uploaded to COVIDENCE platform for information management. Articles were screened by 3 independent reviewers following the eligibility criteria. RESULTS: Twenty-seven articles met the inclusion criteria, spanning information from 568 patients across 16 different countries. None of the studies had complete epidemiological information. Only 2 studies provided sufficient data to address the pathophysiology, while 3 addressed management and treatment. Hearing loss was reported in 210 of 568 patients. A total of 19.2% of patients reported recurrent ear infections. None of the studies reported vertigo, tinnitus, or dizziness in the patients. Pure-tone audiometry was the primary test used to diagnose and monitor auditory impairment in patients with Morquio syndrome. CONCLUSIONS: Five hundred sixty-eight patients with MPS IVA were identified, of whom 210 (37%) developed hearing loss, the most common of which was moderate. Despite the lack of information on the diagnosis and management of hearing loss in Morquio syndrome, this study found that approximately one-third of participants exhibited some form of auditory impairment, with the majority of these cases being sensorineural in nature.
650    _2
$a lidé $7 D006801
650    12
$a mukopolysacharidóza IV $x komplikace $x epidemiologie $x diagnóza $7 D009085
650    12
$a nedoslýchavost $x epidemiologie $x diagnóza $x etiologie $7 D034381
655    _2
$a časopisecké články $7 D016428
655    _2
$a scoping review $7 D000098583
700    1_
$a Duque-Cordoba, Paola Andrea $u Centro de Investigaciones en Anomalías Congénitas y Enfermedades Raras (CIACER), Universidad Iccesi, Cali, Colombia $u Departamento de Ciencias Básicas Médicas, Facultad de Salud, Universidad Icesi, Cali, Colombia
700    1_
$a Silva-Cuero, Katherine $u Centro de Investigaciones en Anomalías Congénitas y Enfermedades Raras (CIACER), Universidad Iccesi, Cali, Colombia $u Departamento de Ciencias Básicas Médicas, Facultad de Salud, Universidad Icesi, Cali, Colombia
700    1_
$a Gutierrez-Medina, Juan David $u Centro de Investigaciones en Anomalías Congénitas y Enfermedades Raras (CIACER), Universidad Iccesi, Cali, Colombia $u Centro de Investigaciones Clínicas, Fundación Valle del Lili, Cali, Colombia
700    1_
$a Saldarriaga, Wilmar $u Centro de Investigaciones Clínicas, Fundación Valle del Lili, Cali, Colombia $u Hospital Universitario del Valle, Cali, Colombia
700    1_
$a Murgašová, Lenka $u Department of Pediatrics and Inherited Metabolic Disorders, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic $u Department of ENT, University Hospital Kralovske Vinohrady and Third Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Magner, Martin $u Department of Pediatrics and Inherited Metabolic Disorders, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic $u Department of Pediatrics, Thomayer's University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Candelo, Estephania $u Centro de Investigaciones Clínicas, Fundación Valle del Lili, Cali, Colombia
700    1_
$a Pachajoa, Harry $u Centro de Investigaciones en Anomalías Congénitas y Enfermedades Raras (CIACER), Universidad Iccesi, Cali, Colombia $u Departamento de Ciencias Básicas Médicas, Facultad de Salud, Universidad Icesi, Cali, Colombia $u Genetic Division, Fundación Valle del Lili, Cali, Colombia
773    0_
$w MED00012436 $t Medicine $x 1536-5964 $g Roč. 104, č. 2 (2025), s. e41128
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39792720 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250415 $b ABA008
991    __
$a 20250429135105 $b ABA008
999    __
$a ok $b bmc $g 2311567 $s 1247365
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 104 $c 2 $d e41128 $e 20250110 $i 1536-5964 $m Medicine $n Medicine (Baltimore) $x MED00012436
LZP    __
$a Pubmed-20250415

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...